Foundayo (Orforglipron) FDA Approved 2026: Eli Lilly's Weight Loss Pill vs Ozempic & Wegovy
FDA approved Eli Lilly's Foundayo (orforglipron) on April 1, 2026 — an oral GLP-1 pill starting at $149/month. Here's how it compares to Ozempic and Wegovy.
Education Press Releases
Education press releases from universities, schools, EdTech companies, and research institutions.
16 press releases found
Best Creatine Gummies 2026: 8 Ranked — Which Actually Contain Real Creatine?
Creatine gummy searches are up 1,300%. But do they work? We ranked the 8 best creatine gummies of 2026 by dose, purity, taste, and value.
Bangladeshi Author Publishes Debut English Novel Independently — Now Available in 14 Countries Including Japan, Canada and the United States
Mir Ahadul Islam from Dhaka, Bangladesh has independently published The Teeth Beneath — a dark romance thriller now available on Amazon, Apple Books and 14 other platforms across 1…
Best Antihistamine 2026: Zyrtec vs Claritin vs Allegra vs Xyzal Ranked
Which allergy pill actually works best in 2026? We compare Zyrtec, Claritin, Allegra, and Xyzal on speed, drowsiness, cost, and real-world effectiveness.
Worst Cities for Allergies in 2026: AAFA Rankings and How to Survive
Boise tops the 2026 Allergy Capitals list. We break down the top 20 worst cities, why pollen is worse than ever, and which antihistamine actually works best.
Best Longevity Supplements 2026: Ranked by Science, Not Hype
We reviewed 685+ clinical trials to rank the top longevity supplements for 2026. Here's what actually works — and what's wasting your money.
Orforglipron vs Ozempic vs Mounjaro 2026: Pill or Injection?
Compare orforglipron, Ozempic, and Mounjaro head-to-head on weight loss, cost, side effects, and convenience as Eli Lilly's oral GLP-1 pill nears FDA approval.
WayUp Abroad Now Offers Management Quota Admission in UK for Indian Students
Expanding opportunities for Indian students to study in UK with flexible admission options and expert guidance
M&M's Recall Hits 20 States Over Missing Allergen Warnings
Beacon Promotions Inc. recalls repackaged M&M's in 20 states. Packages lack required allergen labels for milk, soy, and peanuts; FDA classifies the recall as Class II.
Ozempic vs Wegovy vs Mounjaro: How the Weight-Loss Drugs Compare in 2025
Ozempic and Wegovy use semaglutide; Mounjaro uses tirzepatide. In head-to-head trials, tirzepatide led to greater weight loss. Here's the comparison and what to discuss with your d…
Medicare Open Enrollment 2026: Dates, Premium Changes, and What to Do
Medicare open enrollment for 2026 runs October 15–December 7, 2025. Premiums drop, drug cap hits $2,100, and vaccines are free. What to know.
ChatGPT Health: How 40 Million People Use AI for Healthcare Questions
OpenAI says 40 million people use ChatGPT for health-related queries. ChatGPT Health can use medical records. Here's what that means and the risks.
Wegovy Pill Approved as GLP-1 Supply Eases and Pricing Shifts in 2026
Novo Nordisk's oral Wegovy received FDA approval in January 2026. Supply shortages have eased while government pricing deals and weight-regain data reshape the obesity drug market.
CDC Finds Silent Bird Flu Infections in U.S. Dairy Veterinarians
A CDC serosurvey of 150 bovine veterinarians found three with undetected H5N1 infections. Two had no known exposure to infected herds, suggesting wider spread than official counts.
Moderna mRNA Flu Vaccine Clears FDA Hurdle, Decision Set for August
Moderna's mRNA flu vaccine mRNA-1010 wins FDA review after initial rejection, with a decision date of August 5, 2026 for potential approval.
Retatrutide Phase 3 Data Shows 29% Weight Loss, Rivaling Surgery
Eli Lilly's retatrutide triple agonist achieves 28.7% weight loss in TRIUMPH-4 trial, matching bariatric surgery outcomes and reshaping obesity treatment.